Target intelligence / Profile preview

MicroRNA 1297 (miR-1297)

Target
miR-1297
Molecular classification
MicroRNA, Non-coding RNA, Gene expression regulator
01

Overview

MicroRNA 1297 is a small, non-coding RNA that functions as a gene expression regulator by binding to target mRNAs and suppressing their translation or promoting degradation. It has context-dependent roles in cancer, acting as a tumor suppressor in glioma, colorectal cancer, and hepatocellular carcinoma by inducing cell cycle arrest and apoptosis. Conversely, in some cancers, it can act as an oncogene by downregulating tumor suppressor genes such as PTEN and activating growth pathways. miR-1297 targets include HMGA1, PTEN, TRIB2, CCND2, COX2, MTDH, and others. Its expression profile and regulatory activity make it a promising biomarker and candidate target for therapeutic intervention, although clinical applications face challenges typical for microRNA-based therapies such as off-target effects and delivery issues.

Other names
hsa-mir-1297MIR1297MIRN1297mir-1297
02

Mechanism of action

Drugs or molecules that modulate miR-1297 typically act by either inhibiting its expression or restoring its function via mimics/antagomirs, leading to altered downstream gene expression (e.g., targeting HMGA1, PTEN, TRIB2, CCND2, COX2, MTDH)

03

Biological functions

Regulation of gene expression (post-transcriptional)Cell cycle arrest (G1/S phase)Induction of apoptosisModulation of cell proliferation
04

Disease associations

Cancer (tumor suppressor or oncogene depending on context: glioma, hepatocellular carcinoma, colorectal cancer, lung adenocarcinoma, squamous cell carcinoma)Possible roles in other disorders linked to deregulated cell proliferation or apoptosis
05

Safety considerations

Systemic manipulation may impact multiple targets and signaling pathways, leading to unpredictable side effects (e.g., off-target gene silencing, immune response)As with other RNA-based therapies, delivery, stability, and tissue specificity remain significant therapeutic challenges
06

Biomarkers

miR-1297 expression levels in tumor tissue or blood can serve as a biomarker for diagnosis, prognosis, or therapeutic response in several cancers

Beyond the preview

Go deeper on MicroRNA 1297 (miR-1297).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 1297 (miR-1297).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call